|
|
response to antidepressant
|
GO:0036276 |
4 |
0.923
|
|
|
|
regulation of skeletal muscle cell differentiation
|
GO:2001014 |
1 |
0.843
|
|
|
|
response to wounding
|
GO:0009611 |
254 |
0.836
|
Rat |
|
|
tissue development
|
GO:0009888 |
252 |
0.814
|
Human |
|
|
response to metal ion
|
GO:0010038 |
253 |
0.733
|
|
|
|
regulation of cell proliferation
|
GO:0042127 |
359 |
0.731
|
Human |
|
|
negative regulation of blood coagulation
|
GO:0030195 |
6 |
0.730
|
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
17 |
0.619
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
1 |
0.614
|
|
|
|
regulation of cellular component organization
|
GO:0051128 |
368 |
0.589
|
Human Rat |
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
18 |
0.547
|
|
|
|
response to inorganic substance
|
GO:0010035 |
377 |
0.541
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
223 |
0.540
|
|
|
|
programmed cell death
|
GO:0012501 |
392 |
0.532
|
Human |
|
|
single organism catabolic process
|
GO:0044712 |
283 |
0.526
|
|
|
|
negative regulation of wound healing
|
GO:0061045 |
8 |
0.522
|
|
|
|
response to methylmercury
|
GO:0051597 |
16 |
0.515
|
|
|
|
reproductive structure development
|
GO:0048608 |
128 |
0.515
|
|
|
|
chronic inflammatory response
|
GO:0002544 |
16 |
0.511
|
|
|
|
cell cell signaling
|
GO:0007267 |
335 |
0.510
|
|
|
|
inflammatory cell apoptotic process
|
GO:0006925 |
5 |
0.494
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
1 |
0.486
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
341 |
0.470
|
Human |
|
|
cellular response to stress
|
GO:0033554 |
269 |
0.469
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
203 |
0.459
|
Rat |
|
|
central nervous system development
|
GO:0007417 |
311 |
0.431
|
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
18 |
0.429
|
|
|
|
gliogenesis
|
GO:0042063 |
93 |
0.410
|
|
|
|
prolactin secretion
|
GO:0070459 |
2 |
0.394
|
|
|
|
negative regulation of skeletal muscle tissue development
|
GO:0048642 |
3 |
0.394
|
|
|
|
catabolic process
|
GO:0009056 |
351 |
0.393
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
56 |
0.390
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
9 |
0.386
|
|
|
|
negative regulation of phospholipase a2 activity
|
GO:1900138 |
1 |
0.382
|
|
|
|
single organism biosynthetic process
|
GO:0044711 |
342 |
0.354
|
|
|
|
negative regulation of skeletal muscle cell differentiation
|
GO:2001015 |
1 |
0.353
|
|
|
|
immune system process
|
GO:0002376 |
204 |
0.340
|
Human |
|
|
neutrophil apoptotic process
|
GO:0001781 |
4 |
0.337
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
125 |
0.335
|
Rat |
|
|
regulation of metal ion transport
|
GO:0010959 |
118 |
0.331
|
Human |
|
|
dna strand renaturation
|
GO:0000733 |
1 |
0.322
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
281 |
0.319
|
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
346 |
0.318
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
21 |
0.316
|
|
|
|
neuron differentiation
|
GO:0030182 |
368 |
0.307
|
Rat |
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
39 |
0.292
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
83 |
0.283
|
|
|
|
regulation of apoptotic process
|
GO:0042981 |
335 |
0.278
|
Human |
|
|
organic substance catabolic process
|
GO:1901575 |
316 |
0.276
|
|
|
|
biological phase
|
GO:0044848 |
17 |
0.271
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
126 |
0.271
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
19 |
0.267
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
194 |
0.258
|
|
|
|
apoptotic process
|
GO:0006915 |
381 |
0.255
|
Human |
|
|
hepatocyte differentiation
|
GO:0070365 |
8 |
0.254
|
|
|
|
rna biosynthetic process
|
GO:0032774 |
380 |
0.250
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
179 |
0.249
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
283 |
0.248
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
122 |
0.246
|
|
|
|
cellular response to corticosteroid stimulus
|
GO:0071384 |
69 |
0.245
|
|
|
|
positive regulation of multicellular organismal process
|
GO:0051240 |
387 |
0.241
|
|
|
|
cellular catabolic process
|
GO:0044248 |
295 |
0.241
|
|
|
|
telencephalon development
|
GO:0021537 |
62 |
0.237
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
68 |
0.234
|
|
|
|
cellular response to lipid
|
GO:0071396 |
201 |
0.229
|
|
|
|
negative regulation of gene expression
|
GO:0010629 |
199 |
0.229
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
17 |
0.226
|
|
|
|
regeneration
|
GO:0031099 |
163 |
0.226
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
181 |
0.223
|
Human |
|
|
negative regulation of metabolic process
|
GO:0009892 |
331 |
0.218
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
202 |
0.215
|
Rat |
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
316 |
0.211
|
|
|
|
response to ethanol
|
GO:0045471 |
162 |
0.210
|
|
|
|
single organism reproductive process
|
GO:0044702 |
297 |
0.208
|
|
|
|
response to corticosteroid
|
GO:0031960 |
235 |
0.208
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
157 |
0.204
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
386 |
0.201
|
Rat |
|
|
protein targeting to membrane
|
GO:0006612 |
11 |
0.200
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
6 |
0.200
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
279 |
0.200
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
249 |
0.194
|
|
|
|
response to estrogen
|
GO:0043627 |
232 |
0.192
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
38 |
0.191
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
152 |
0.189
|
|
|
|
synaptic transmission
|
GO:0007268 |
235 |
0.189
|
|
|
|
cell migration
|
GO:0016477 |
197 |
0.189
|
Human |
|
|
wound healing
|
GO:0042060 |
122 |
0.188
|
|
|
|
cation transport
|
GO:0006812 |
382 |
0.184
|
Human |
|
|
positive regulation of prostaglandin biosynthetic process
|
GO:0031394 |
5 |
0.179
|
|
|
|
regulation of sperm motility
|
GO:1901317 |
2 |
0.177
|
|
|
|
hippocampus development
|
GO:0021766 |
30 |
0.177
|
|
|
|
oxoacid metabolic process
|
GO:0043436 |
290 |
0.176
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
4 |
0.176
|
|
|
|
regulation of phospholipase activity
|
GO:0010517 |
12 |
0.176
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
119 |
0.175
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
168 |
0.175
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
147 |
0.174
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
37 |
0.173
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
23 |
0.173
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
106 |
0.172
|
|
|
|
lipid metabolic process
|
GO:0006629 |
283 |
0.170
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
70 |
0.170
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
235 |
0.168
|
|
|
|
anatomical structure morphogenesis
|
GO:0009653 |
298 |
0.168
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
34 |
0.166
|
|
|
|
response to acid chemical
|
GO:0001101 |
222 |
0.164
|
|
|
|
intracellular transport
|
GO:0046907 |
185 |
0.164
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
150 |
0.161
|
Human |
|
|
localization of cell
|
GO:0051674 |
202 |
0.161
|
Human |
|
|
negative regulation of response to stimulus
|
GO:0048585 |
155 |
0.161
|
Human |
|
|
negative regulation of protein processing
|
GO:0010955 |
47 |
0.160
|
|
|
|
dna duplex unwinding
|
GO:0032508 |
3 |
0.158
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
165 |
0.157
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
221 |
0.156
|
|
|
|
response to bacterium
|
GO:0009617 |
200 |
0.154
|
|
|
|
regulation of rna metabolic process
|
GO:0051252 |
391 |
0.154
|
|
|
|
regulation of metalloenzyme activity
|
GO:0048552 |
1 |
0.152
|
|
|
|
regulation of locomotion
|
GO:0040012 |
148 |
0.152
|
Human |
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
14 |
0.152
|
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
260 |
0.151
|
|
|
|
regulation of phosphorylation
|
GO:0042325 |
248 |
0.151
|
|
|
|
response to folic acid
|
GO:0051593 |
14 |
0.147
|
|
|
|
rna metabolic process
|
GO:0016070 |
406 |
0.146
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
99 |
0.143
|
Rat |
|
|
regulation of catalytic activity
|
GO:0050790 |
304 |
0.143
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
136 |
0.143
|
|
|
|
response to nutrient
|
GO:0007584 |
248 |
0.142
|
|
|
|
protein targeting to plasma membrane
|
GO:0072661 |
4 |
0.142
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
365 |
0.142
|
Human |
|
|
intracellular signal transduction
|
GO:0035556 |
314 |
0.141
|
|
|
|
mast cell cytokine production
|
GO:0032762 |
1 |
0.139
|
|
|
|
peptide secretion
|
GO:0002790 |
86 |
0.138
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
141 |
0.137
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
36 |
0.136
|
|
|
|
response to peptide
|
GO:1901652 |
292 |
0.135
|
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
349 |
0.135
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
138 |
0.133
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
253 |
0.132
|
|
|
|
glial cell differentiation
|
GO:0010001 |
65 |
0.131
|
|
|
|
negative regulation of lipase activity
|
GO:0060192 |
3 |
0.131
|
|
|
|
nucleic acid templated transcription
|
GO:0097659 |
379 |
0.129
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
122 |
0.129
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
38 |
0.128
|
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
161 |
0.127
|
|
|
|
regulation of nucleic acid templated transcription
|
GO:1903506 |
380 |
0.126
|
|
|
|
regulation of cell development
|
GO:0060284 |
263 |
0.126
|
Rat |
|
|
calcium ion transport
|
GO:0006816 |
131 |
0.124
|
Human |
|
|
regulation of molecular function
|
GO:0065009 |
398 |
0.123
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
83 |
0.122
|
|
|
|
organophosphate metabolic process
|
GO:0019637 |
370 |
0.122
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
247 |
0.122
|
Rat |
|
|
estrous cycle phase
|
GO:0060206 |
15 |
0.121
|
|
|
|
dna geometric change
|
GO:0032392 |
4 |
0.120
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
124 |
0.120
|
|
|
|
response to amino acid
|
GO:0043200 |
75 |
0.119
|
|
|
|
limbic system development
|
GO:0021761 |
38 |
0.118
|
|
|
|
protein phosphorylation
|
GO:0006468 |
345 |
0.117
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
122 |
0.117
|
|
|
|
locomotion
|
GO:0040011 |
237 |
0.117
|
Human |
|
|
ribonucleotide metabolic process
|
GO:0009259 |
231 |
0.116
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
48 |
0.115
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
120 |
0.115
|
|
|
|
response to nutrient levels
|
GO:0031667 |
370 |
0.112
|
|
|
|
response to zinc ion
|
GO:0010043 |
39 |
0.112
|
|
|
|
urogenital system development
|
GO:0001655 |
78 |
0.111
|
|
|
|
protein localization to membrane
|
GO:0072657 |
36 |
0.111
|
|
|
|
response to ketone
|
GO:1901654 |
182 |
0.111
|
|
|
|
single organism intracellular transport
|
GO:1902582 |
166 |
0.109
|
|
|
|
response to other organism
|
GO:0051707 |
220 |
0.109
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
121 |
0.107
|
Human |
|
|
homeostatic process
|
GO:0042592 |
331 |
0.106
|
Rat |
|
|
hepaticobiliary system development
|
GO:0061008 |
90 |
0.106
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
55 |
0.105
|
|
|
|
cell motility
|
GO:0048870 |
202 |
0.105
|
Human |
|
|
regulation of protein metabolic process
|
GO:0051246 |
289 |
0.104
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
99 |
0.102
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
72 |
0.102
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
84 |
0.102
|
|
|
|
transcription dna templated
|
GO:0006351 |
377 |
0.102
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
138 |
0.101
|
|
|
|
protein maturation
|
GO:0051604 |
68 |
0.099
|
|
|
|
brain development
|
GO:0007420 |
247 |
0.099
|
|
|
|
cellular component movement
|
GO:0006928 |
248 |
0.097
|
Human |
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
229 |
0.097
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
15 |
0.097
|
|
|
|
regulation of ion transport
|
GO:0043269 |
245 |
0.095
|
Human |
|
|
cellular response to reactive oxygen species
|
GO:0034614 |
55 |
0.095
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
191 |
0.095
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
227 |
0.095
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
133 |
0.095
|
|
|
|
response to axon injury
|
GO:0048678 |
59 |
0.094
|
Rat |
|
|
acute inflammatory response
|
GO:0002526 |
58 |
0.093
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
91 |
0.092
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
68 |
0.092
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
21 |
0.091
|
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
319 |
0.090
|
|
|
|
cellular macromolecule localization
|
GO:0070727 |
122 |
0.089
|
|
|
|
protein complex subunit organization
|
GO:0071822 |
302 |
0.089
|
|
|
|
cellular protein localization
|
GO:0034613 |
122 |
0.088
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
159 |
0.088
|
|
|
|
dna rewinding
|
GO:0036292 |
1 |
0.087
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
376 |
0.086
|
Rat |
|
|
positive regulation of ion transmembrane transporter activity
|
GO:0032414 |
13 |
0.086
|
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
161 |
0.086
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
2 |
0.085
|
|
|
|
response to estradiol
|
GO:0032355 |
164 |
0.083
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
13 |
0.083
|
|
|
|
cellular component biogenesis
|
GO:0044085 |
368 |
0.082
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
2 |
0.082
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
229 |
0.082
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
182 |
0.080
|
|
|
|
positive regulation of transport
|
GO:0051050 |
245 |
0.080
|
Human |
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
36 |
0.078
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.077
|
Human |
|
|
defense response
|
GO:0006952 |
194 |
0.076
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
29 |
0.076
|
|
|
|
positive regulation of transporter activity
|
GO:0032411 |
14 |
0.075
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
36 |
0.074
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
94 |
0.074
|
Human |
|
|
growth
|
GO:0040007 |
165 |
0.073
|
|
|
|
blood vessel development
|
GO:0001568 |
69 |
0.073
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
83 |
0.073
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
202 |
0.073
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
93 |
0.071
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
7 |
0.071
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
27 |
0.071
|
|
|
|
cell projection organization
|
GO:0030030 |
302 |
0.071
|
Rat |
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
36 |
0.071
|
Human |
|
|
heterocycle catabolic process
|
GO:0046700 |
167 |
0.071
|
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
295 |
0.070
|
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
118 |
0.070
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
77 |
0.070
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
377 |
0.069
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
176 |
0.069
|
|
|
|
regulation of prostaglandin biosynthetic process
|
GO:0031392 |
5 |
0.068
|
|
|
|
proteolysis
|
GO:0006508 |
175 |
0.068
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
163 |
0.067
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
184 |
0.067
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
6 |
0.067
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
33 |
0.065
|
|
|
|
response to cytokine
|
GO:0034097 |
215 |
0.065
|
|
|
|
cytoskeleton organization
|
GO:0007010 |
111 |
0.065
|
|
|
|
regulation of rna biosynthetic process
|
GO:2001141 |
381 |
0.064
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
264 |
0.064
|
Rat |
|
|
nucleotide catabolic process
|
GO:0009166 |
139 |
0.063
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
58 |
0.063
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
144 |
0.063
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
178 |
0.062
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
48 |
0.062
|
|
|
|
response to interleukin 1
|
GO:0070555 |
55 |
0.062
|
|
|
|
positive regulation of calcium ion transmembrane transporter activity
|
GO:1901021 |
7 |
0.062
|
|
|
|
macromolecular complex subunit organization
|
GO:0043933 |
339 |
0.061
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
88 |
0.061
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
237 |
0.060
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
62 |
0.060
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
63 |
0.060
|
|
|
|
reproductive process
|
GO:0022414 |
372 |
0.060
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
175 |
0.059
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
56 |
0.059
|
|
|
|
negative regulation of muscle organ development
|
GO:0048635 |
8 |
0.058
|
|
|
|
response to calcium ion
|
GO:0051592 |
59 |
0.058
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
50 |
0.058
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
16 |
0.057
|
|
|
|
cell adhesion
|
GO:0007155 |
110 |
0.057
|
Rat |
|
|
positive regulation of adenylate cyclase activity
|
GO:0045762 |
12 |
0.056
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
124 |
0.056
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
208 |
0.056
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
81 |
0.056
|
|
|
|
muscle tissue development
|
GO:0060537 |
58 |
0.056
|
|
|
|
endocrine system development
|
GO:0035270 |
30 |
0.056
|
|
|
|
tissue regeneration
|
GO:0042246 |
36 |
0.056
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
141 |
0.056
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.055
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
168 |
0.055
|
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
2 |
0.055
|
|
|
|
positive regulation of phosphate metabolic process
|
GO:0045937 |
262 |
0.054
|
|
|
|
pallium development
|
GO:0021543 |
42 |
0.054
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
38 |
0.054
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
134 |
0.053
|
Human |
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.053
|
Human |
|
|
gland development
|
GO:0048732 |
155 |
0.053
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
89 |
0.053
|
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
267 |
0.052
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
38 |
0.052
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
23 |
0.052
|
|
|
|
biological adhesion
|
GO:0022610 |
110 |
0.052
|
Rat |
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
84 |
0.051
|
|
|
|
response to oxygen levels
|
GO:0070482 |
265 |
0.051
|
|
|
|
negative regulation of nitric oxide biosynthetic process
|
GO:0045019 |
5 |
0.051
|
|
|
|
prostate gland development
|
GO:0030850 |
9 |
0.051
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
35 |
0.051
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
33 |
0.050
|
|
|
|
inflammatory response
|
GO:0006954 |
150 |
0.050
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
119 |
0.050
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
136 |
0.049
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
82 |
0.049
|
|
|
|
rubidium ion transport
|
GO:0035826 |
1 |
0.049
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
123 |
0.048
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
208 |
0.048
|
Rat |
|
|
negative regulation of transport
|
GO:0051051 |
136 |
0.048
|
Human |
|
|
actin filament based process
|
GO:0030029 |
86 |
0.048
|
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
349 |
0.047
|
|
|
|
positive regulation of transmembrane transport
|
GO:0034764 |
25 |
0.047
|
Human |
|
|
peptide hormone secretion
|
GO:0030072 |
84 |
0.047
|
|
|
|
cell morphogenesis
|
GO:0000902 |
142 |
0.047
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
124 |
0.046
|
|
|
|
single organism cellular localization
|
GO:1902580 |
102 |
0.046
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
49 |
0.046
|
|
|
|
response to hypoxia
|
GO:0001666 |
231 |
0.046
|
|
|
|
organelle organization
|
GO:0006996 |
266 |
0.046
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
126 |
0.046
|
|
|
|
autophagic cell death
|
GO:0048102 |
4 |
0.045
|
|
|
|
protein processing
|
GO:0016485 |
68 |
0.045
|
|
|
|
aging
|
GO:0007568 |
241 |
0.045
|
|
|
|
norepinephrine metabolic process
|
GO:0042415 |
3 |
0.045
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
169 |
0.045
|
|
|
|
metal ion transport
|
GO:0030001 |
289 |
0.045
|
Human |
|
|
regulation of cell differentiation
|
GO:0045595 |
320 |
0.044
|
Rat |
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
37 |
0.044
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
1 |
0.044
|
|
|
|
endomembrane system organization
|
GO:0010256 |
48 |
0.043
|
|
|
|
regulation of cyclase activity
|
GO:0031279 |
21 |
0.042
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
122 |
0.042
|
|
|
|
regulation of protein modification process
|
GO:0031399 |
194 |
0.042
|
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
148 |
0.042
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
114 |
0.042
|
|
|
|
atp catabolic process
|
GO:0006200 |
54 |
0.042
|
|
|
|
negative regulation of humoral immune response
|
GO:0002921 |
4 |
0.041
|
|
|
|
glial cell development
|
GO:0021782 |
19 |
0.041
|
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
153 |
0.041
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
154 |
0.041
|
|
|
|
regulation of transcription dna templated
|
GO:0006355 |
374 |
0.041
|
|
|
|
regulation of adenylate cyclase activity
|
GO:0045761 |
18 |
0.040
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
126 |
0.040
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
47 |
0.040
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
81 |
0.040
|
Human |
|
|
cellular response to vascular endothelial growth factor stimulus
|
GO:0035924 |
6 |
0.040
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
177 |
0.039
|
|
|
|
regulation of protein phosphorylation
|
GO:0001932 |
183 |
0.039
|
|
|
|
blood circulation
|
GO:0008015 |
183 |
0.039
|
|
|
|
regulation of necroptotic process
|
GO:0060544 |
2 |
0.039
|
|
|
|
muscle structure development
|
GO:0061061 |
87 |
0.038
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
18 |
0.038
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
283 |
0.037
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
226 |
0.037
|
|
|
|
collecting duct development
|
GO:0072044 |
1 |
0.037
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
1 |
0.037
|
|
|
|
coagulation
|
GO:0050817 |
28 |
0.037
|
|
|
|
carboxylic acid metabolic process
|
GO:0019752 |
289 |
0.037
|
|
|
|
macromolecular complex assembly
|
GO:0065003 |
273 |
0.037
|
|
|
|
prostaglandin biosynthetic process
|
GO:0001516 |
12 |
0.036
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
334 |
0.036
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
98 |
0.036
|
|
|
|
epithelium development
|
GO:0060429 |
96 |
0.036
|
Human |
|
|
regulation of cytokine production
|
GO:0001817 |
56 |
0.036
|
|
|
|
nerve development
|
GO:0021675 |
11 |
0.036
|
|
|
|
response to vitamin
|
GO:0033273 |
131 |
0.036
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
91 |
0.036
|
|
|
|
positive regulation of phosphorus metabolic process
|
GO:0010562 |
262 |
0.036
|
|
|
|
regulation of muscle organ development
|
GO:0048634 |
26 |
0.036
|
|
|
|
pancreas development
|
GO:0031016 |
19 |
0.035
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
85 |
0.035
|
|
|
|
behavior
|
GO:0007610 |
205 |
0.035
|
|
|
|
regulation of signal transduction
|
GO:0009966 |
318 |
0.035
|
Human |
|
|
atp metabolic process
|
GO:0046034 |
72 |
0.035
|
|
|
|
response to carbohydrate
|
GO:0009743 |
183 |
0.035
|
Rat |
|
|
sperm motility
|
GO:0030317 |
5 |
0.035
|
|
|
|
head development
|
GO:0060322 |
247 |
0.035
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
9 |
0.035
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
155 |
0.035
|
|
|
|
glial cell migration
|
GO:0008347 |
11 |
0.034
|
|
|
|
cellular component assembly
|
GO:0022607 |
360 |
0.034
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
72 |
0.034
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
41 |
0.034
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
1 |
0.034
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
143 |
0.034
|
|
|
|
regulation of cellular extravasation
|
GO:0002691 |
2 |
0.034
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
252 |
0.033
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
140 |
0.033
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
70 |
0.033
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
22 |
0.033
|
|
|
|
multicellular organismal reproductive process
|
GO:0048609 |
233 |
0.033
|
|
|
|
prostaglandin metabolic process
|
GO:0006693 |
12 |
0.033
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
103 |
0.033
|
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
141 |
0.032
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
19 |
0.032
|
|
|
|
membrane fusion
|
GO:0061025 |
26 |
0.032
|
|
|
|
positive regulation of cyclase activity
|
GO:0031281 |
15 |
0.032
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
141 |
0.032
|
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
319 |
0.031
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
102 |
0.031
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
380 |
0.031
|
|
|
|
astrocyte development
|
GO:0014002 |
4 |
0.031
|
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
168 |
0.031
|
|
|
|
macrophage chemotaxis
|
GO:0048246 |
2 |
0.031
|
Human |
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
135 |
0.031
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
101 |
0.030
|
|
|
|
single organism membrane organization
|
GO:0044802 |
74 |
0.030
|
|
|
|
positive regulation of cell communication
|
GO:0010647 |
271 |
0.030
|
|
|
|
nucleobase containing compound catabolic process
|
GO:0034655 |
152 |
0.030
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
48 |
0.030
|
|
|
|
intracellular protein transport
|
GO:0006886 |
79 |
0.030
|
|
|
|
protein homooligomerization
|
GO:0051260 |
91 |
0.030
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
118 |
0.030
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
46 |
0.030
|
Rat |
|
|
cation transmembrane transport
|
GO:0098655 |
263 |
0.030
|
|
|
|
regulation of protein transport
|
GO:0051223 |
68 |
0.030
|
|
|
|
arp2 3 complex mediated actin nucleation
|
GO:0034314 |
2 |
0.028
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
187 |
0.028
|
|
|
|
response to peptide hormone
|
GO:0043434 |
278 |
0.028
|
|
|
|
positive regulation of signaling
|
GO:0023056 |
270 |
0.028
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
179 |
0.028
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
8 |
0.028
|
|
|
|
signal release
|
GO:0023061 |
145 |
0.028
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
85 |
0.028
|
|
|
|
response to monosaccharide
|
GO:0034284 |
159 |
0.028
|
Rat |
|
|
cellular ketone metabolic process
|
GO:0042180 |
51 |
0.028
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
50 |
0.027
|
|
|
|
amide transport
|
GO:0042886 |
105 |
0.027
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
60 |
0.027
|
|
|
|
negative regulation of transcription dna templated
|
GO:0045892 |
116 |
0.027
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
134 |
0.027
|
Human |
|
|
protein oligomerization
|
GO:0051259 |
191 |
0.027
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
52 |
0.027
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
42 |
0.027
|
Human |
|
|
peptide transport
|
GO:0015833 |
97 |
0.027
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
47 |
0.027
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
46 |
0.027
|
Rat |
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
117 |
0.027
|
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
218 |
0.027
|
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
234 |
0.027
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
2 |
0.026
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
82 |
0.026
|
Rat |
|
|
insulin secretion
|
GO:0030073 |
69 |
0.026
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
71 |
0.026
|
Human |
|
|
female pregnancy
|
GO:0007565 |
122 |
0.026
|
|
|
|
organic acid metabolic process
|
GO:0006082 |
292 |
0.026
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
55 |
0.026
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
55 |
0.026
|
|
|
|
developmental growth
|
GO:0048589 |
100 |
0.025
|
|
|
|
cellular response to ketone
|
GO:1901655 |
51 |
0.025
|
|
|
|
skeletal system development
|
GO:0001501 |
41 |
0.025
|
|
|
|
multicellular organism reproduction
|
GO:0032504 |
233 |
0.025
|
|
|
|
protein complex assembly
|
GO:0006461 |
263 |
0.025
|
|
|
|
axon development
|
GO:0061564 |
96 |
0.025
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
136 |
0.025
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
62 |
0.025
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
59 |
0.024
|
|
|
|
protein complex biogenesis
|
GO:0070271 |
263 |
0.024
|
|
|
|
regulation of growth
|
GO:0040008 |
105 |
0.024
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
85 |
0.024
|
|
|
|
regulation of secretion
|
GO:0051046 |
224 |
0.024
|
|
|
|
negative regulation of acute inflammatory response
|
GO:0002674 |
4 |
0.024
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
174 |
0.024
|
|
|
|
hexose metabolic process
|
GO:0019318 |
58 |
0.023
|
|
|
|
response to oxidative stress
|
GO:0006979 |
186 |
0.023
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
93 |
0.023
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
229 |
0.023
|
Human |
|
|
divalent metal ion transport
|
GO:0070838 |
132 |
0.023
|
Human |
|
|
positive regulation of cell differentiation
|
GO:0045597 |
217 |
0.023
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.023
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
148 |
0.023
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
25 |
0.023
|
|
|
|
blood coagulation
|
GO:0007596 |
26 |
0.023
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
83 |
0.023
|
Human Rat |
|
|
myeloid cell apoptotic process
|
GO:0033028 |
6 |
0.022
|
|
|
|
response to interferon alpha
|
GO:0035455 |
1 |
0.022
|
|
|
|
protein targeting
|
GO:0006605 |
61 |
0.022
|
|
|
|
establishment of protein localization
|
GO:0045184 |
141 |
0.022
|
|
|
|
antigen processing and presentation of peptide or polysaccharide antigen via mhc class ii
|
GO:0002504 |
1 |
0.022
|
|
|
|
axonogenesis
|
GO:0007409 |
71 |
0.022
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.022
|
|
|
|
inflammatory response to antigenic stimulus
|
GO:0002437 |
18 |
0.022
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
110 |
0.021
|
|
|
|
neuron development
|
GO:0048666 |
286 |
0.021
|
Rat |
|
|
regulation of cell migration
|
GO:0030334 |
128 |
0.021
|
Human |
|
|
response to manganese ion
|
GO:0010042 |
13 |
0.021
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
49 |
0.021
|
|
|
|
vascular endothelial growth factor signaling pathway
|
GO:0038084 |
4 |
0.021
|
|
|
|
protein homotrimerization
|
GO:0070207 |
15 |
0.021
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
46 |
0.021
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
7 |
0.021
|
|
|
|
reproductive system development
|
GO:0061458 |
128 |
0.021
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
52 |
0.021
|
Rat |
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
38 |
0.021
|
|
|
|
inorganic anion transport
|
GO:0015698 |
41 |
0.021
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
247 |
0.020
|
|
|
|
forebrain development
|
GO:0030900 |
98 |
0.020
|
|
|
|
tissue remodeling
|
GO:0048771 |
40 |
0.020
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
135 |
0.020
|
|
